Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Study of Tetrandrine Tablets Adjuvant Treatment With COVID-19

NCT04308317 is registered in ClinicalTrials.gov with Henan Provincial People's Hospital as lead sponsor.

NCT NCT04308317
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04308317 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Study of Tetrandrine Tablets Adjuvant Treatment With COVID-19
Lead sponsor
Henan Provincial People's Hospital
Phase
Phase 4
Overall status
Unknown status
Start date
March 5, 2020
Completion date
May 1, 2021
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

corona virus disease 2019,covid-19